Molecular Formula | C19H24FN5O7S |
Molar Mass | 485.49 |
Melting Point | 235-2370C |
Solubility | DMSO (Slightly), Methanol (Slightly, Heated), Water (Slightly) |
Appearance | powder |
Color | white to light brown |
Storage Condition | room temp |
Stability | Hygroscopic |
Safety Description | 24/25 - Avoid contact with skin and eyes. |
HS Code | 29339900 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.06 ml | 10.299 ml | 20.598 ml |
5 mM | 0.412 ml | 2.06 ml | 4.12 ml |
10 mM | 0.206 ml | 1.03 ml | 2.06 ml |
5 mM | 0.041 ml | 0.206 ml | 0.412 ml |
product description | jimfloxacin mesylate (domestic trade name: jisuxing) is the fourth generation of fluoroquinolone antibacterial drug jointly developed by LG of South Korea and GSK of Britain. it was approved by FDA to be listed in the United States in April 2003 and SFDA to be listed in China in July 2006. |
product use | jimfloxacin mesylate is a fluoroquinolone antibacterial drug. As a new oral broad-spectrum fluoroquinolone antibiotic, jimfloxacin mesylate has a good effect on the common pathogens of respiratory tract infection, Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and atypical pathogens. |
biological activity | Gemifloxacin mesylate is an oral broad-spectrum quinolone antibacterial agent used in the study of acute bacterial attacks of chronic bronchitis and mild to moderate pneumonia. |